サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1314967

末梢神経損傷の世界市場規模調査＆予測、製品別、用途別、手術別、地域別分析、2023-2030年

Global Peripheral Nerve Injuries Market Size study & Forecast, by Product, By Application, by Surgery and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
末梢神経損傷の世界市場規模調査＆予測、製品別、用途別、手術別、地域別分析、2023-2030年
出版日: 2023年07月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の末梢神経損傷市場は、2022年に約14億3,000万米ドルと評価され、予測期間2023～2030年には7.65%以上の健全な成長率で成長すると予測されています。

末梢神経損傷には、末梢神経系の機能障害として現れる幅広い臨床症状が含まれます。末梢神経損傷は一般的な病態であり、その重症度や影響を受ける神経によってさまざまな症状を引き起こす可能性があります。末梢神経損傷により、患者は軽度の不快感から完全な麻痺まで経験する可能性があります。末梢神経の損傷は、脱力感、しびれ、不快感などの症状を示すことが多いです。しかし、世界の末梢神経損傷治療薬市場は、末梢神経損傷に対する認識の高まりと、病気を管理するための薬剤や治療薬による治療によって牽引される可能性が高いです。さらに、PNIの罹患率の上昇が治療市場の収益成長に影響を及ぼしています。

末梢神経損傷市場は、慢性疾患の有病率の上昇により金額ベースで成長しています。国立衛生研究所によると、2022年には末梢神経の問題が人口の2.4%に影響し、そのうち8.0%は高齢者人口に属します。2021年には、国際糖尿病連合によって、糖尿病に罹患している成人は世界で約5億3,700万人になり、10人に1人は他の糖尿病も経験すると予測されています。糖尿病性神経障害は、1型糖尿病と2型糖尿病の両方に関連する神経障害であり、これらの慢性疾患を持つ人の約50％が罹患しています。ハンセン病による末梢神経損傷は、現在でも世界中で広く見られる問題です。さらに、高齢者や肥満の人は慢性疾患を発症しやすいです。世界銀行グループによると、世界の高齢者人口は2020年に7億2,700万人となり、今後30年間で3倍に増え、2050年には15億人に達すると予想されています。末梢神経損傷の重点的治療に関する研究開発活動の増加や、医師や看護師が迅速な診断と適切な患者ケアを提供できるようにするための教育強化が不可欠であることが、市場の成長を牽引しています。しかし、医師も患者もまだこの症候群の蔓延に気づいていない可能性があり、これが成長を制限する要因のひとつとなっています。また、この疾患の治療のための理学療法が利用可能であることも、2023～2030年の予測期間を通じて市場の拡大を妨げています。

末梢神経損傷の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカなどです。北米は2022年の市場を独占しました。北米は予測期間で最大の収益シェアを占めると予想されます。これは、同地域で新たな治療オプションがイントロダクションされたためです。さらに、ヘルスケア支出の増加や治療法の選択肢が増えたことも、同地域における末梢神経損傷市場の収益成長を後押しすると思われます。さらに、この疾患に対する認知度の向上が市場の収益成長につながっています。これらの要因が、予測期間中に同地域の末梢神経損傷市場の収益成長を促進すると予測されます。アジア太平洋地域は、中国やインドなどの国々で高齢者の数が大幅に増加しているなどの要因により、予測期間中に大きく成長すると予想されます。さらに、ジェネリック医薬品メーカーの存在や、同地域におけるヘルスケア施設の拡大が、同地域の収益成長の主要因となっています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • 末梢神経損傷市場：地域別、2020-2030年
    • 末梢神経損傷市場：製品別、2020-2030年
    • 末梢神経損傷市場：用途別、2020-2030年
    • 末梢神経損傷市場：手術別、2020-2030年
  • 主要動向
  • 調査手法
  • 調査前提

第2章 末梢神経損傷の世界市場定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 末梢神経損傷の世界市場力学

  • 末梢神経損傷市場のインパクト分析（2020-2030年）
    • 市場促進要因
      • PNIの発生率の増加
      • 末梢神経損傷とその治療薬・治療法に対する認識の高まり
    • 市場の課題
      • 末梢神経損傷に関する医師や患者の認識不足
      • 障害治療のための理学療法の利用可能性
    • 市場機会
      • 迅速な診断を行うための医師や看護師に対する教育需要の高まり
      • 末梢神経損傷の重点的治療のための研究開発の増加

第4章 末梢神経損傷の世界市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 末梢神経損傷の世界市場：製品別

  • 市場スナップショット
  • 末梢神経損傷の世界市場：製品別、実績 - ポテンシャル分析
  • 末梢神経損傷の世界市場：製品別、推定・予測：2020-2030年
  • 末梢神経損傷市場、サブセグメント別分析
    • 神経導管
    • 神経プロテクター
    • 神経コネクタ
    • 神経ラップ

第6章 末梢神経損傷の世界市場：用途別

  • 市場スナップショット
  • 末梢神経損傷の世界市場：用途別、実績 -潜在能力分析
  • 末梢神経損傷の世界市場：用途別推定・予測2020-2030年
  • 末梢神経損傷市場、サブセグメント別分析
    • 上肢
    • 下肢

第7章 末梢神経損傷の世界市場：手術別

  • 市場スナップショット
  • 末梢神経損傷の世界市場：手術別、実績 -潜在能力分析
  • 末梢神経損傷の世界市場：手術別推定・予測2020-2030年
  • 末梢神経損傷市場、サブセグメント別分析
    • 直接神経修復術
    • 神経移植
    • 幹細胞治療

第8章 末梢神経損傷の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 末梢神経損傷市場、地域別市場スナップショット
  • 北米
    • 米国
      • 製品の推定・予測、2020-2030年
      • 用途別推定・予測、2020-2030年
      • 手術別の推定・予測、2020-2030年
    • カナダ
  • 欧州末梢神経損傷市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋末梢神経損傷市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの末梢神経損傷市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • AxoGen, Inc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Stryker
    • Baxter International, Inc.
    • Polyganics BV
    • Integra Lifesciences Corp.
    • Renerva, LLC.
    • Medovent GmbH
    • Toyobo Co., Ltd
    • Medtronic plc
    • Stryker Corporation

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提
図表

LIST OF TABLES

  • TABLE 1. Global Peripheral Nerve Injuries Market, report scope
  • TABLE 2. Global Peripheral Nerve Injuries Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Peripheral Nerve Injuries Market estimates & forecasts by Product 2020-2030 (USD Billion)
  • TABLE 4. Global Peripheral Nerve Injuries Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Peripheral Nerve Injuries Market estimates & forecasts by Surgery 2020-2030 (USD Billion)
  • TABLE 6. Global Peripheral Nerve Injuries Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Peripheral Nerve Injuries Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Peripheral Nerve Injuries Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Peripheral Nerve Injuries Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Peripheral Nerve Injuries Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Peripheral Nerve Injuries Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Peripheral Nerve Injuries Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Peripheral Nerve Injuries Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Peripheral Nerve Injuries Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Peripheral Nerve Injuries Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Peripheral Nerve Injuries Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Peripheral Nerve Injuries Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Peripheral Nerve Injuries Market
  • TABLE 71. List of primary sources, used in the study of global Peripheral Nerve Injuries Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Peripheral Nerve Injuries Market, research methodology
  • FIG 2. Global Peripheral Nerve Injuries Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Peripheral Nerve Injuries Market, key trends 2022
  • FIG 5. Global Peripheral Nerve Injuries Market, growth prospects 2023-2030
  • FIG 6. Global Peripheral Nerve Injuries Market, porters 5 force model
  • FIG 7. Global Peripheral Nerve Injuries Market, pest analysis
  • FIG 8. Global Peripheral Nerve Injuries Market, value chain analysis
  • FIG 9. Global Peripheral Nerve Injuries Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Peripheral Nerve Injuries Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Peripheral Nerve Injuries Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Peripheral Nerve Injuries Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Peripheral Nerve Injuries Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Peripheral Nerve Injuries Market, regional snapshot 2020 & 2030
  • FIG 15. North America Peripheral Nerve Injuries Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Peripheral Nerve Injuries Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Peripheral Nerve Injuries Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Peripheral Nerve Injuries Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Peripheral Nerve Injuries Market 2020 & 2030 (USD Billion)

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

目次

Global Peripheral Nerve Injuries Market is valued at approximately USD 1.43 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.65% over the forecast period 2023-2030. Peripheral nerve injury includes a broad range of clinical conditions that may present as peripheral nervous system dysfunction. Peripheral nerve injuries are a common condition that can result in a variety of symptoms depending on the severity and nerves affected. Peripheral nerve injuries can cause patients to experience anything from minor discomfort to complete paralysis. Peripheral nerve damage frequently presents with symptoms of weakness, numbness, and discomfort. However, the global peripheral nerve injury therapeutics market is likely to be driven by increased awareness of peripheral nerve injury and its treatment through drugs and therapies to manage the illness. Furthermore, the rising incidence rate of PNIs influences the revenue growth of the treatment market.

The market for peripheral nerve injuries is growing in terms of value due to the rising prevalence of chronic disorders. According to the National Institute of Health, In 2022, peripheral nerve issues impact 2.4% of the population among which 8.0% belongs to the elderly populations. In 2021, it was projected by the International Diabetes Federation that there would be approximately 537 million adults worldwide affected by diabetes, and one out of every ten individuals would also experience other forms of diabetes. Diabetic neuropathy, which is nerve damage associated with both type 1 and type 2 diabetes, affects around 50% of people with these chronic conditions. Peripheral nerve damage from leprosy is still a widespread problem worldwide. Additionally, elderly individuals and those who are obese are more prone to developing chronic illnesses. According to the World Bank Group, the global elderly population stood at 727 million in 2020, and it is expected to triple in the next 30 years, reaching 1.5 billion by 2050. The market's revenue growth is being driven by an increase in research and development activities for focused treatment of peripheral nerve injury as well as the vital requirement for more education for doctors and nurses to enable them to provide prompt diagnoses and appropriate patient care. However, doctors and patients may both still be unaware of the syndrome's prevalence is one of the factors limiting growth. The availability of physical therapy for the disorder's treatment also hinders the market's expansion throughout the forecast period of 2023-2030.

The key regions considered for the Global Peripheral Nerve Injuries Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022. North America is expected to account for the largest revenue share over the forecast period. This is due to the introduction of new treatment options in the region. Furthermore, increased healthcare expenditures, as well as the availability of treatment choices, would help drive revenue growth of peripheral nerve injuries market in the region. Moreover, rising awareness of the disease has led to revenue growth in the market. These factors are expected to drive revenue growth of the peripheral nerve injury market in the region over the forecast period. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as the number of elderly people has significantly increased in nations such as China and India. Additionally, the presence of generic drug makers and the expansion of healthcare facilities in the area are key factors in the region's revenue growth.

Major market player included in this report are:

  • AxoGen, Inc.
  • Stryker
  • Baxter International, Inc.
  • Polyganics BV
  • Integra Lifesciences Corp.
  • Renerva, LLC.
  • Medovent GmbH
  • Toyobo Co., Ltd
  • Medtronic plc
  • Stryker Corporation

Recent Developments in the Market:

  • In March 2022, Integra LifeSciences Holding Corp. announced the release of the 3D Nerve Guide Matrix, also known as NeuraGen, a resorbable implant for the healing of peripheral nerve discontinuities.
  • In April 2021, on the Zernike Campus in Groningen, Polyganics, a medical technology company that develops, manufactures, and sells bioresorbable medical devices, constructed a new facility. The facility is designed to support Polyganics' ongoing development, manufacturing, and sales operations, further advancing their innovative medical device solutions.

Global Peripheral Nerve Injuries Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimatio: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product, Application, Surgery, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

  • Nerve Conduit
  • Nerve Protector
  • Nerve Connector
  • Nerve Wraps

By Application:

  • Upper Extremities
  • Lower Extremities

By Surgery:

  • Direct Nerve Repair
  • Nerve Grafting
  • Stem Cell Therapy

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Peripheral Nerve Injuries Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Peripheral Nerve Injuries Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3. Peripheral Nerve Injuries Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Peripheral Nerve Injuries Market, by Surgery, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Peripheral Nerve Injuries Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Peripheral Nerve Injuries Market Dynamics

  • 3.1. Peripheral Nerve Injuries Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing Incidence of PNIs
      • 3.1.1.2. Growing awareness of Peripheral nerve injury and its treatment through drugs and therapies
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of Awareness among doctors and patients about Peripheral Nerve Injuries
      • 3.1.2.2. Availability of physical therapy for the disorder's treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising Demand for more education for doctors and nurses to provide prompt diagnoses
      • 3.1.3.2. Increasing research and development activities for focused treatment of peripheral nerve injury

Chapter 4. Global Peripheral Nerve Injuries Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Peripheral Nerve Injuries Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Peripheral Nerve Injuries Market by Product, Performance - Potential Analysis
  • 5.3. Global Peripheral Nerve Injuries Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4. Peripheral Nerve Injuries Market, Sub Segment Analysis
    • 5.4.1. Nerve Conduit
    • 5.4.2. Nerve Protector
    • 5.4.3. Nerve Connector
    • 5.4.4. Nerve Wraps

Chapter 6. Global Peripheral Nerve Injuries Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Peripheral Nerve Injuries Market by Application, Performance - Potential Analysis
  • 6.3. Global Peripheral Nerve Injuries Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Peripheral Nerve Injuries Market, Sub Segment Analysis
    • 6.4.1. Upper Extremities
    • 6.4.2. Lower Extremities

Chapter 7. Global Peripheral Nerve Injuries Market, by Surgery

  • 7.1. Market Snapshot
  • 7.2. Global Peripheral Nerve Injuries Market by Surgery, Performance - Potential Analysis
  • 7.3. Global Peripheral Nerve Injuries Market Estimates & Forecasts by Surgery 2020-2030 (USD Billion)
  • 7.4. Peripheral Nerve Injuries Market, Sub Segment Analysis
    • 7.4.1. Direct Nerve Repair
    • 7.4.2. Nerve Grafting
    • 7.4.3. Stem Cell Therapy

Chapter 8. Global Peripheral Nerve Injuries Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Peripheral Nerve Injuries Market, Regional Market Snapshot
  • 8.4. North America Peripheral Nerve Injuries Market
    • 8.4.1. U.S. Peripheral Nerve Injuries Market
      • 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Surgery breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Peripheral Nerve Injuries Market
  • 8.5. Europe Peripheral Nerve Injuries Market Snapshot
    • 8.5.1. U.K. Peripheral Nerve Injuries Market
    • 8.5.2. Germany Peripheral Nerve Injuries Market
    • 8.5.3. France Peripheral Nerve Injuries Market
    • 8.5.4. Spain Peripheral Nerve Injuries Market
    • 8.5.5. Italy Peripheral Nerve Injuries Market
    • 8.5.6. Rest of Europe Peripheral Nerve Injuries Market
  • 8.6. Asia-Pacific Peripheral Nerve Injuries Market Snapshot
    • 8.6.1. China Peripheral Nerve Injuries Market
    • 8.6.2. India Peripheral Nerve Injuries Market
    • 8.6.3. Japan Peripheral Nerve Injuries Market
    • 8.6.4. Australia Peripheral Nerve Injuries Market
    • 8.6.5. South Korea Peripheral Nerve Injuries Market
    • 8.6.6. Rest of Asia Pacific Peripheral Nerve Injuries Market
  • 8.7. Latin America Peripheral Nerve Injuries Market Snapshot
    • 8.7.1. Brazil Peripheral Nerve Injuries Market
    • 8.7.2. Mexico Peripheral Nerve Injuries Market
  • 8.8. Middle East & Africa Peripheral Nerve Injuries Market
    • 8.8.1. Saudi Arabia Peripheral Nerve Injuries Market
    • 8.8.2. South Africa Peripheral Nerve Injuries Market
    • 8.8.3. Rest of Middle East & Africa Peripheral Nerve Injuries Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. AxoGen, Inc.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Stryker
    • 9.3.3. Baxter International, Inc.
    • 9.3.4. Polyganics BV
    • 9.3.5. Integra Lifesciences Corp.
    • 9.3.6. Renerva, LLC.
    • 9.3.7. Medovent GmbH
    • 9.3.8. Toyobo Co., Ltd
    • 9.3.9. Medtronic plc
    • 9.3.10. Stryker Corporation

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption